D
SAB Biotherapeutics, Inc. SABS
$2.19 $0.13956.79% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- 114.70K -- 263.10K
Total Other Revenue -- -- -- -- --
Total Revenue -- -- 114.70K -- 263.10K
Cost of Revenue 7.00M 7.66M 7.65M 7.83M 6.82M
Gross Profit -7.00M -7.66M -7.54M -7.83M -6.56M
SG&A Expenses 2.74M 3.11M 2.47M 3.48M 3.64M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 9.73M 10.77M 10.12M 11.31M 10.46M
Operating Income -9.73M -10.77M -10.01M -11.31M -10.20M
Income Before Tax -10.11M -5.20M -11.39M -10.35M -7.34M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -10.11M -5.20M -11.39M -10.35M -7.34M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -10.11M -5.20M -11.39M -10.35M -7.34M
EBIT -9.73M -10.77M -10.01M -11.31M -10.20M
EBITDA -8.96M -9.99M -9.22M -10.34M -9.15M
EPS Basic -1.09 -0.56 -1.23 -1.12 -0.79
Normalized Basic EPS -0.68 -0.35 -0.77 -0.70 -0.50
EPS Diluted -1.09 -0.56 -1.23 -1.12 -0.79
Normalized Diluted EPS -0.68 -0.35 -0.77 -0.70 -0.50
Average Basic Shares Outstanding 9.29M 9.29M 9.29M 9.26M 9.26M
Average Diluted Shares Outstanding 9.29M 9.29M 9.29M 9.26M 9.26M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --